FDA 21 CFR Part 11 compliance — electronic records and signatures done right

21 CFR Part 11 is a regulation issued by the US Food and Drug Administration (FDA) that defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. It was enacted in 1997 and applies to all FDA-regulated industries including pharmaceuticals, biotechnology, medical devices, and food manufacturing. The regulation covers system validation, audit trails, access controls, and electronic signature requirements.

Yes. Q-Hub is designed from the ground up to support 21 CFR Part 11 compliance. The platform provides all the technical controls required by the regulation: system validation with IQ/OQ/PQ documentation, immutable audit trails on every record, compliant electronic signatures with name, date, time, and meaning, role-based access controls with MFA, and cryptographic binding of signatures to records. Q-Hub also provides the validation documentation you need to demonstrate compliance to FDA inspectors.

EU GMP Annex 11 is the European equivalent to 21 CFR Part 11, governing computerised systems used in GMP-regulated environments. While the two regulations have different structures, they share similar requirements around system validation, data integrity, audit trails, and access controls. Q-Hub satisfies both frameworks simultaneously, making it ideal for organisations that manufacture or distribute products in both the US and EU markets. One validated system covers both regulatory frameworks.

Q-Hub electronic signatures comply with Subpart C of 21 CFR Part 11. Every signature captures the signer's full name, the date and time of signing, and the meaning of the signature (such as "authored", "reviewed", or "approved"). Signatures are cryptographically bound to the record they sign, ensuring they cannot be transferred, copied, or falsified. Each user has a unique account with no shared logins, and authentication uses username plus password with configurable password complexity, expiry, and account lockout policies.

Q-Hub provides comprehensive validation documentation as part of your implementation, including: Validation Plan, User Requirements Specification (URS), Functional Requirements Specification (FRS), Installation Qualification (IQ) protocols, Operational Qualification (OQ) protocols, Performance Qualification (PQ) protocols, traceability matrices linking requirements to test cases, risk assessments, and a Validation Summary Report. This documentation reduces validation effort by approximately 50% compared to building everything from scratch.

Yes. Q-Hub enables you to move from paper-based batch records to fully electronic batch records that comply with 21 CFR Part 11. Electronic batch records in Q-Hub include all the controls required by the regulation: audit trails recording every creation and modification, electronic signatures for review and approval steps, access controls ensuring only authorised personnel can create or modify records, and the ability to generate legible, accurate copies in both human-readable and electronic form. Many of our pharmaceutical customers have eliminated paper batch records entirely.